IN THE NEWS
January 19, 2026
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
‘Yale New Haven Health’s new microsurgery robot improving lives’
Robotic microsurgery is transforming care for lymphedema patients, enabling surgeons with enhanced precision to perform challenging reconstructive procedures such as lymphatic repair. At Yale Medicine, Dr. Luccie Wo, Plastic Reconstructive Surgeon, used the Symani Surgical System to perform lymphovenous bypass (LVB) surgery for patient Angela Suphin, who developed painful swelling in her right arm following breast cancer treatment in 2023. The robotic-assisted procedure relieved Angela’s pain and restored mobility, just in time for her to hold her newborn grandson.
News8 spotlighted her experience and how Yale New Haven Health is advancing treatment options for lymphedema patients with a technology-enabled approach to microsurgery.
This story was produced by and is copyright of WTNH News 8. Read the full news article here.
Related News
MMI Introduces World’s First Microsurgical Suture for Robotics
MMI Introduces World’s First Microsurgical Suture for Robotics
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
World-first robotic throat surgery at Melbourne hospital saves patient’s voice and ability to eat
